{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:29:11Z","timestamp":1792038551981,"version":"4.4.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2018.00246","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T04:28:39Z","timestamp":1536208119000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Classification and Outcome Measures for Psoriatic Arthritis"],"prefix":"10.3389","volume":"5","author":[{"given":"Ying Ying","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Ogdie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Orbai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Tillett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Strand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Mease","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna D.","family":"Gladman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/rheumatology\/keq262","article-title":"Observational cohort studies: lessons learnt from the University of Toronto psoriatic arthritis program","volume":"50","author":"Gladman","year":"2011","journal-title":"Rheumatology"},{"key":"B2","first-page":"2409","article-title":"Progression in psoriatic arthritis: role of time varying clinical indicators","volume":"26","author":"Gladman","year":"1999","journal-title":"J Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/ard.2006.056457","article-title":"Predictors for radiological damage in psoriatic arthritis: results from a single centre","volume":"66","author":"Bond","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/1471-2474-15-284","article-title":"Predictors of functional deterioration in Chinese patients with psoriatic arthritis: a longitudinal study","volume":"15","author":"Leung","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13075-015-0570-0","article-title":"Cumulative inflammatory burden is independently associated with increased arterial stiffness in patients with psoriatic arthritis: a prospective study","volume":"17","author":"Shen","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jdv.12163","article-title":"Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review","volume":"27","author":"Horreau","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N","article-title":"Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death","volume":"41","author":"Gladman","year":"1998","journal-title":"Arthritis Rheum."},{"key":"B8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/annrheumdis-2012-202424","article-title":"Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study","volume":"73","author":"Ogdie","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard.2008.102053","article-title":"Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment","volume":"69","author":"Coates","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/art.22003","article-title":"Development of classification and response criteria for rheumatic diseases","volume":"55","author":"Singh","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/acr.22583","article-title":"Distinctions between diagnostic and classification criteria?","volume":"67","author":"Aggarwal","year":"2015","journal-title":"Arthritis Care Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","article-title":"Psoriatic arthritis","volume":"3","author":"Moll","year":"1973","journal-title":"Semin Arthritis Rheum."},{"key":"B13","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1136\/ard.2004.032318","article-title":"Classification and diagnostic criteria for psoriatic arthritis","volume":"64","author":"Helliwell","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","article-title":"The epidemiology of psoriatic arthritis","volume":"41","author":"Ogdie","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"B15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.semarthrit.2004.05.001","article-title":"A comparison of the performance characteristics of classification criteria for the diagnosis of psoriatic arthritis","volume":"34","author":"Taylor","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The european spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"key":"B18","first-page":"151","article-title":"Psoriatic arthropathy","volume-title":"Spondyloarthropathies.","author":"Vasey","year":"1984"},{"key":"B19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11926-004-0042-z","article-title":"Development of diagnostic criteria for psoriatic arthritis: methods and process","volume":"6","author":"Taylor","year":"2004","journal-title":"Curr Rheumatol Rep"},{"key":"B20","unstructured":"Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis in a family medicine clinic setting206970\n            ChandranV\n            SchentagCT\n            GladmanDD\n          18843760J Rheumatol.352008"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1002\/art.34536","article-title":"Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis","volume":"64","author":"Coates","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3899\/jrheum.110845","article-title":"The classification for psoriatic arthritis (CASPAR) criteria\u2013a retrospective feasibility, sensitivity, and specificity study","volume":"39","author":"Tillett","year":"2012","journal-title":"J Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/rheumatology\/kep348","article-title":"Evaluation of the CASPAR criteria for psoriatic arthritis in the Chinese population","volume":"49","author":"Leung","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3899\/jrheum.140182","article-title":"Development of criteria to distinguish inflammatory from noninflammatory arthritis, enthesitis, dactylitis, and spondylitis: a report from the GRAPPA 2013 annual meeting","volume":"41","author":"Mease","year":"2014","journal-title":"J Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The assessment of spondyloarthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1136\/annrheumdis-2011-201081","article-title":"Performance of classification criteria for peripheral spondyloarthritis and psoriatic arthritis in the leiden early arthritis cohort","volume":"71","author":"van","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"ii9","DOI":"10.1136\/ard.2004.033654","article-title":"Seronegative spondyloarthropathies: to lump or split?","volume":"64","author":"Nash","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11926-013-0317-3","article-title":"Classification criteria: peripheral spondyloarthropathy and psoriatic arthritis","volume":"15","author":"Taylor","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"ii49","DOI":"10.1136\/ard.2004.034165","article-title":"Psoriatic arthritis assessment tools in clinical trials","volume":"64","author":"Mease","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"839425","DOI":"10.1155\/2012\/839425","article-title":"Measuring disease activity in psoriatic arthritis","volume":"2012","author":"Wong","year":"2012","journal-title":"Int J Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/art.37939","article-title":"Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease","volume":"65","author":"Coates","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B33","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1186\/ar3049","article-title":"Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT","volume":"12","author":"Gladman","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"B34","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/acr.22401","article-title":"Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients","volume":"67","author":"Eder","year":"2015","journal-title":"Arthritis Care Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1002\/acr.20577","article-title":"Measures of psoriatic arthritis: tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander\/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI)","volume":"63","author":"Mease","year":"2011","journal-title":"Arthritis Care Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/annrheumdis-2017-211447","article-title":"How are enthesitis, dactylitis and nail involvement measured and reported in recent clinical trials of psoriatic arthritis? A systematic literature review","volume":"77","author":"Ramiro","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e000217","DOI":"10.1136\/rmdopen-2015-000217","article-title":"Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set","volume":"2","author":"Kalyoncu","year":"2016","journal-title":"RMD Open"},{"key":"B38","first-page":"198","article-title":"The OMERACT filter for outcome measures in rheumatology","volume":"25","author":"Boers","year":"1998","journal-title":"J Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jclinepi.2013.11.013","article-title":"Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0","volume":"67","author":"Boers","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"B40","unstructured":"Consensus on a core set of domains for psoriatic arthritis116770\n            GladmanDD\n            MeasePJ\n            StrandV\n            HealyP\n            HelliwellPS\n            FitzgeraldO\n          17477480J Rheumatol.342007"},{"key":"B41","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/ard.2010.135129","article-title":"European league against rheumatism recommendations for the inclusion of patient representatives in scientific projects","volume":"70","author":"de","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e002241","DOI":"10.1136\/bmjopen-2012-002241","article-title":"Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences","volume":"3","author":"de","year":"2013","journal-title":"BMJ Open"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.3899\/jrheum.141156","article-title":"Enhanced patient involvement and the need to revise the core set - report from the psoriatic arthritis working group at OMERACT 2014","volume":"42","author":"Tillett","year":"2015","journal-title":"J Rheumatol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3899\/jrheum.160904","article-title":"Updating the psoriatic arthritis (PsA) core domain set: a report from the PsA workshop at OMERACT 2016","volume":"44","author":"Orbai","year":"2017","journal-title":"J Rheumatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/annrheumdis-2016-210242","article-title":"International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials","volume":"76","author":"Orbai","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3899\/jrheum.170150","article-title":"Defining outcome measures for psoriatic arthritis: a report from the GRAPPA-OMERACT working group","volume":"44","author":"Ogdie","year":"2017","journal-title":"J Rheumatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.semarthrit.2017.09.002","article-title":"A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: a GRAPPA-OMERACT initiative","volume":"47","author":"Hojgaard","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"B48","article-title":"Systematic literature review of systemic inflammation, using Creactive protein and erythrocyte sedimentation rate, in psoriatic arthritis to inform the development of instruments for the updated psoriatic arthritis core outcome measurement Set","author":"Elmamoun","year":"","journal-title":"J Rheumatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00246\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T04:29:14Z","timestamp":1536208154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00246\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,6]]},"references-count":48,"alternative-id":["10.3389\/fmed.2018.00246"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2018.00246","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,6]]},"article-number":"246"}}